Rahway, NJ, United States of America

Reed Larson

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Merck Sharp & Dohme LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Reed Larson. Retrieved from https://idiyas.com/inventor/reed-larson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 19.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Reed Larson: Pharmaceutical Chemistry Inventor

Introduction

Reed Larson is an inventor based in Rahway, New Jersey, whose patent work is associated with Merck Sharp & Dohme LLC. His listed invention concerns the synthesis of a BTK inhibitor and its intermediates.

Latest Patents

Larson is credited with 1 patent: “Synthesis of BTK Inhibitor and Intermediates Thereof.” The patent focuses on methods for preparing a BTK inhibitor and related intermediate compounds.

Career Highlights

Larson’s listed patent reflects work in pharmaceutical chemistry and the development of processes for synthesizing compounds relevant to drug research. His professional association with Merck Sharp & Dohme LLC connects this work to the company’s pharmaceutical research activities.

Collaborations

Larson’s listed coworkers include Richard Desmond and Jeffrey T. Kuethe. Their shared association with the patent points to collaborative work on the synthesis methods and intermediates described in it.

Conclusion

Reed Larson’s patent record highlights his contribution to pharmaceutical synthesis through work on a BTK inhibitor and its intermediates at Merck Sharp & Dohme LLC.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…